BEAM
Price
$29.02
Change
+$2.17 (+8.08%)
Updated
Dec 20, 04:59 PM (EDT)
72 days until earnings call
DNLI
Price
$21.46
Change
-$0.03 (-0.14%)
Updated
Dec 20, 04:59 PM (EDT)
71 days until earnings call
Ad is loading...

BEAM vs DNLI

Header iconBEAM vs DNLI Comparison
Open Charts BEAM vs DNLIBanner chart's image
Beam Therapeutics
Price$29.02
Change+$2.17 (+8.08%)
Volume$37.3K
CapitalizationN/A
Denali Therapeutics
Price$21.46
Change-$0.03 (-0.14%)
Volume$23.05K
CapitalizationN/A
BEAM vs DNLI Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. DNLI commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and DNLI is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (BEAM: $29.01 vs. DNLI: $21.45)
Brand notoriety: BEAM and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 220% vs. DNLI: 320%
Market capitalization -- BEAM: $2.4B vs. DNLI: $3.09B
BEAM [@Biotechnology] is valued at $2.4B. DNLI’s [@Biotechnology] market capitalization is $3.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while DNLI’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 4 bearish.
  • DNLI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than DNLI.

Price Growth

BEAM (@Biotechnology) experienced а +3.87% price change this week, while DNLI (@Biotechnology) price change was -6.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

DNLI is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.09B) has a higher market cap than BEAM($2.41B). BEAM YTD gains are higher at: 6.576 vs. DNLI (-0.047). BEAM has higher annual earnings (EBITDA): -160.83M vs. DNLI (-496.05M). BEAM has more cash in the bank: 926M vs. DNLI (837M). DNLI has less debt than BEAM: DNLI (52.5M) vs BEAM (162M). BEAM has higher revenues than DNLI: BEAM (350M) vs DNLI (0).
BEAMDNLIBEAM / DNLI
Capitalization2.41B3.09B78%
EBITDA-160.83M-496.05M32%
Gain YTD6.576-0.047-14,115%
P/E RatioN/AN/A-
Revenue350M0-
Total Cash926M837M111%
Total Debt162M52.5M309%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMDNLI
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSESX16.610.18
+1.10%
Russell Inv US Strategic Equity S
HSLIX44.720.40
+0.90%
Hartford Small Cap Growth I
VBIAX50.330.38
+0.76%
Vanguard Balanced Index Adm
GFGEX12.76-0.90
-6.58%
Guardian Fundamental Glb Eq instl
JCAVX9.07-1.01
-10.01%
JHFunds2 Capital Appreciation Value NAV

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+8.04%
CRSP - BEAM
72%
Closely correlated
+0.83%
NTLA - BEAM
66%
Loosely correlated
+0.83%
DNLI - BEAM
64%
Loosely correlated
-0.19%
PRME - BEAM
62%
Loosely correlated
+3.94%
RXRX - BEAM
61%
Loosely correlated
-0.99%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-0.19%
BEAM - DNLI
64%
Loosely correlated
+8.04%
JANX - DNLI
55%
Loosely correlated
+0.14%
NTLA - DNLI
55%
Loosely correlated
+0.83%
LGND - DNLI
54%
Loosely correlated
+0.61%
CRSP - DNLI
53%
Loosely correlated
+0.83%
More